The WorldWide Antimalarial Resistance Network (WWARN) is a collaborative platform generating innovative resources and reliable evidence to inform the malaria community on the factors affecting the efficacy of antimalarial medicines.
What is WWARN?

The WorldWide Antimalarial Resistance Network (WWARN) – part of IDDO - is a collaborative research network that is assessing antimalarial drug efficacy by providing policy makers with the evidence needed to plan effective strategies to contain resistance and ensure the most effective use of current and new drugs in the fight to eradicate malaria. A small increase in malaria drug efficacy could have a major impact by stopping millions of cases of recurrent malaria each year.

WWARNnews

WWARN provides regular updates on our events, activities and milestones. Read our latest newsletter.
 

WWARN toolkit

The Malaria Clinical Trials Toolkit is a pathway with a step by step guide for researchers on how to plan, design, execute and interpret malaria clinical trial results. It helps researchers to think of the different aspects of a malaria clinical trial and how to collect reliable and comprehensive evidence in a standardised format.

Tracking resistance

WWARN's interactive mapping tools monitor and track the emergence and spread of antimalarial resistance across time and geographic location.

Study groups

WWARN facilitates a number of collaborative groups to undertake pooled analyses of data to answer specific research questions about malaria drug resistance.

News

Please visit WWARN's website for regular updates on malaria.